Last reviewed · How we verify

Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU

Seoul National University Hospital · Phase 2 active Small molecule Quality 0/100

Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU is a Small molecule drug developed by Seoul National University Hospital. It is currently in Phase 2 development. Also known as: Antithrombin-III Human 500IU.

At a glance

Generic nameFreeze-dried Concentrated Human Antithrombin Ⅲ 500 IU
Also known asAntithrombin-III Human 500IU
SponsorSeoul National University Hospital
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU

What is Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU?

Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU is a Small molecule drug developed by Seoul National University Hospital.

Who makes Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU?

Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU is developed by Seoul National University Hospital (see full Seoul National University Hospital pipeline at /company/seoul-national-university-hospital).

Is Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU also known as anything else?

Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU is also known as Antithrombin-III Human 500IU.

What development phase is Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU in?

Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU is in Phase 2.

Related